Atai Life Sciences Shares Outstanding 2020-2024 | ATAI
Atai Life Sciences shares outstanding from 2020 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Atai Life Sciences Annual Shares Outstanding (Millions of Shares) |
2023 |
159 |
2022 |
156 |
2021 |
138 |
2020 |
93 |
2019 |
87 |
Atai Life Sciences Quarterly Shares Outstanding (Millions of Shares) |
2024-09-30 |
161 |
2024-06-30 |
160 |
2024-03-31 |
159 |
2023-12-31 |
159 |
2023-09-30 |
178 |
2023-06-30 |
156 |
2023-03-31 |
156 |
2022-12-31 |
156 |
2022-09-30 |
157 |
2022-06-30 |
154 |
2022-03-31 |
154 |
2021-12-31 |
138 |
2021-09-30 |
151 |
2021-06-30 |
132 |
2021-03-31 |
121 |
2020-12-31 |
93 |
2020-09-30 |
91 |
2020-06-30 |
91 |
2020-03-31 |
94 |
2019-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Outpatient & Home Care |
$0.290B |
$0.000B |
atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN.
|